日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Driving consistency: CEPI-Centralized Laboratory Network's conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines

提高一致性:CEPI-中央实验室网络针对用于评估新冠疫苗有效性的SARS-CoV-2临床检测的转换因子计划

Azizi, Ali; Kamuyu, Gathoni; Ogbeni, Deborah; Levesque-Damphousse, Philipa; Knott, Daniel; Gagnon, Luc; Phay-Tran, Steven; Hussey, Bethan; Proud, Pamela; Charlton, Sue; Clark, Carolyn; Bernasconi, Valentina

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

Com-COV2 研究中异源 COVID 疫苗接种方案的免疫反应持久性——一项包含 mRNA 疫苗、病毒载体疫苗和蛋白佐剂疫苗的单盲随机试验

Shaw, Robert H; Greenland, Melanie; Stuart, Arabella S V; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Goodman, Anna L; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Lambe, Teresa; Libri, Vincenzo; Lillie, Patrick J; Morey, Ella; Mujadidi, Yama F; Payne, Ruth; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Screaton, Gavin R; Singh, Nisha; Turner, David P J; Turner, Paul J; White, Rachel; Nguyen-Van-Tam, Jonathan S; Liu, Xinxue; Snape, Matthew D

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]

对“在英国接种两剂 ChAdOx1 nCov-19 或 BNT162b2 后,作为第三剂加强针接种的七剂 COVID-19 疫苗的免疫原性持久性:COV-BOOST 试验的三个月分析”的更正 [J Infect 84(6) (2022) 795-813, 5511]

Liu, Xinxue; Munro, Alasdair Ps; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

英国异源和同源新冠疫苗第三剂接种方案后免疫反应的持久性:COV-BOOST试验的八个月分析

Liu, Xinxue; Munro, Alasdair P S; Wright, Annie; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baker, Jonathan; Baxter, David; Bawa, Tanveer; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Fox, Lauren; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Haughney, John; Hicks, Alexander; Jones, Christine E; Kanji, Nasir; van der Klaauw, Agatha A; Libri, Vincenzo; Llewelyn, Martin J; Mansfield, Rebecca; Maallah, Mina; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Belhadef, Hanane Trari; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Stokes, Matthew; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

接种两剂 ChAdOx1 nCov-19 (AZD1222) 后免疫反应的持久性:两项随机对照试验的 1 年随访结果

Voysey, Merryn; Flaxman, Amy; Aboagye, Jeremy; Aley, Parvinder K; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; Charlton, Sue; Clutterbuck, Elizabeth A; Davies, Sophie; Dold, Christina; Edwards, Nick J; Ewer, Katie J; Faust, Saul N; Folegatti, Pedro M; Fowler, Jamie; Gilbride, Ciaran; Gilbert, Sarah C; Godfrey, Leila; Hallis, Bassam; Humphries, Holly E; Jenkin, Daniel; Kerridge, Simon; Mujadidi, Yama F; Plested, Emma; Ramasamy, Maheshi N; Robinson, Hannah; Sanders, Helen; Snape, Matthew D; Song, Rinn; Thomas, Kelly M; Ulaszewska, Marta; Woods, Danielle; Wright, Daniel; Pollard, Andrew J; Lambe, Teresa

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents

利用康复者血浆、疫苗接种者血清和标准试剂进行真实病毒中和试验,评估SARS-CoV-2基因变异的生物学影响

Coombes, Naomi S; Bewley, Kevin R; Le Duff, Yann; Hurley, Matthew; Smith, Lauren J; Weldon, Thomas M; Osman, Karen; Pullan, Steven; Berry, Neil; Hallis, Bassam; Charlton, Sue; Hall, Yper; Funnell, Simon G P

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines

用纯化的伯氏考克斯体I期脂多糖进行免疫接种,可使小鼠获得部分保护,且该保护作用独立于同时接种的腺病毒载体疫苗。

Dold, Christina; Zhu, Henderson; Silva-Reyes, Laura; Blackwell, Luke; Linder, Aline; Bewley, Kevin; Godwin, Kerry; Fotheringham, Susan; Charlton, Sue; Kim, Young Chan; Pollard, Andrew J; Rollier, Christine S

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

在英国开展的一项单盲、随机、II期非劣效性试验(Com-COV2),旨在评估包含mRNA疫苗、病毒载体疫苗和蛋白佐剂疫苗的异源性COVID-19初次免疫接种的免疫原性、安全性和反应原性。

Stuart, Arabella S V; Shaw, Robert H; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J C; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Goodman, Anna L; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Horsington, Bryn M; Lambe, Teresa; Lazarus, Rajeka; Libri, Vincenzo; Lillie, Patrick J; Mujadidi, Yama F; Payne, Ruth; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Screaton, Gavin R; Singh, Nisha; Turner, David P J; Turner, Paul J; Vichos, Iason; White, Rachel; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

在接种两剂 ChAdOx1 nCoV-19 或 BNT162b2 疫苗后,再接种第三剂 BNT162b2 疫苗(COV-BOOST),评估 BNT162b2 和 mRNA-1273 COVID-19 疫苗作为第四剂加强针的安全性、免疫原性和反应原性:一项多中心、双盲、II 期随机试验

Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kanji, Nasir; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Maallah, Mina; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Bawa, Tanveer; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial

在英国,接种两剂 ChAdOx1 nCov-19 或 BNT162b2 疫苗后,再接种第三剂 COVID-19 疫苗,七例患者接种后免疫原性持久性:COV-BOOST 试验的三个月分析

Liu, Xinxue; Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N